Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Feeling older, walking slower-but only if someone's watching. Subjective age is associated with walking speed in the laboratory, but not in real life.

Notthoff N, Drewelies J, Kazanecka P, Steinhagen-Thiessen E, Norman K, Düzel S, Daumer M, Lindenberger U, Demuth I, Gerstorf D.

Eur J Ageing. 2018 Feb 1;15(4):425-433. doi: 10.1007/s10433-017-0450-3. eCollection 2018 Dec.

PMID:
30532679
2.

Physico-chemical, biochemical and nutritional characterisation of 42 organic wastes and residues from France.

Fisgativa H, Marcilhac C, Girault R, Daumer ML, Trémier A, Dabert P, Béline F.

Data Brief. 2018 Jun 22;19:1953-1962. doi: 10.1016/j.dib.2018.06.050. eCollection 2018 Aug.

3.

Multicenter Evaluation of Two Next-Generation HIV-1 Quantitation Assays, Aptima Quant Dx and Cobas 6800, in Comparison to the RealTime HIV-1 Reference Assay.

Wiesmann F, Ehret R, Naeth G, Däumer M, Fuhrmann J, Kaiser R, Noah C, Obermeier M, Schalasta G, Tiemann C, Wolf E, Knechten H, Braun P.

J Clin Microbiol. 2018 Sep 25;56(10). pii: e00292-18. doi: 10.1128/JCM.00292-18. Print 2018 Oct.

4.

Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 Δ32 Homozygous Stem Cells.

Verheyen J, Thielen A, Lübke N, Dirks M, Widera M, Dittmer U, Kordelas L, Däumer M, de Jong DCM, Wensing AMJ, Kaiser R, Nijhuis M, Esser S.

Clin Infect Dis. 2019 Feb 1;68(4):684-687. doi: 10.1093/cid/ciy565.

PMID:
30020413
5.

[Intrapartum Foetal Heart Rate Monitoring and Rate of Caesarean Section: A National Survey].

Schiermeier S, Frisenda S, Reinhard J, Dagres T, Noé KG, Lobmaier S, Schneider KTM, Daumer M.

Z Geburtshilfe Neonatol. 2018 Jun;222(3):117-122. doi: 10.1055/s-0044-102227. Epub 2018 Jun 19. German.

PMID:
29920630
6.

geno2pheno[ngs-freq]: a genotypic interpretation system for identifying viral drug resistance using next-generation sequencing data.

Döring M, Büch J, Friedrich G, Pironti A, Kalaghatgi P, Knops E, Heger E, Obermeier M, Däumer M, Thielen A, Kaiser R, Lengauer T, Pfeifer N.

Nucleic Acids Res. 2018 Jul 2;46(W1):W271-W277. doi: 10.1093/nar/gky349.

7.

Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance.

Fun A, Leitner T, Vandekerckhove L, Däumer M, Thielen A, Buchholz B, Hoepelman AIM, Gisolf EH, Schipper PJ, Wensing AMJ, Nijhuis M.

Retrovirology. 2018 Jan 5;15(1):1. doi: 10.1186/s12977-017-0384-z.

8.

Low clinical conversion rate in clinically isolated syndrome patients - diagnostic benefit of McDonald 2010 criteria?

Rosenkranz SC, Kaulen B, Neuhaus A, Siemonsen S, Köpke S, Daumer M, Stellmann JP, Heesen C.

Eur J Neurol. 2018 Feb;25(2):247-e9. doi: 10.1111/ene.13476. Epub 2017 Dec 2.

PMID:
29024243
9.

Dissolution of particulate phosphorus in pig slurry through biological acidification: A critical step for maximum phosphorus recovery as struvite.

Piveteau S, Picard S, Dabert P, Daumer ML.

Water Res. 2017 Nov 1;124:693-701. doi: 10.1016/j.watres.2017.08.017. Epub 2017 Aug 8.

PMID:
28825986
10.

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.

Widera M, Dirks M, Bleekmann B, Jablonka R, Däumer M, Walter H, Ehret R, Verheyen J, Esser S.

Med Microbiol Immunol. 2017 Jun;206(3):203-215. doi: 10.1007/s00430-017-0494-1. Epub 2017 Feb 20.

11.

A gestational dose of vitamin D per day keeps the MS doctor away.

Marrie RA, Daumer M.

Neurology. 2017 Jan 3;88(1):13-14. doi: 10.1212/WNL.0000000000003469. Epub 2016 Nov 30. No abstract available.

PMID:
27903816
12.

Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.

Bader J, Däumer M, Schöni-Affolter F, Böni J, Gorgievski-Hrisoho M, Martinetti G, Thielen A, Klimkait T; Swiss HIV Cohort Study.

Clin Infect Dis. 2017 Feb 1;64(3):295-300. doi: 10.1093/cid/ciw737. Epub 2016 Nov 12.

PMID:
27838645
13.

Sequencing biological acidification of waste-activated sludge aiming to optimize phosphorus dissolution and recovery.

Guilayn F, Braak E, Piveteau S, Daumer ML.

Environ Technol. 2017 Jun;38(11):1399-1407. doi: 10.1080/09593330.2016.1230653. Epub 2016 Sep 20.

PMID:
27628209
14.

Fampridine and real-life walking in multiple sclerosis: Low predictive value of clinical test for habitual short-term changes.

Stellmann JP, Jlussi M, Neuhaus A, Lederer C, Daumer M, Heesen C.

J Neurol Sci. 2016 Sep 15;368:318-25. doi: 10.1016/j.jns.2016.07.051. Epub 2016 Jul 25.

PMID:
27538657
15.

Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.

Brücher BL, Li Y, Schnabel P, Daumer M, Wallace TJ, Kube R, Zilberstein B, Steele S, Voskuil JL, Jamall IS.

Clin Transl Med. 2016 Mar;5(1):13. doi: 10.1186/s40169-016-0093-6. Epub 2016 Apr 6. Review.

16.

The relationship of age with the clinical phenotype in multiple sclerosis.

Scalfari A, Lederer C, Daumer M, Nicholas R, Ebers GC, Muraro PA.

Mult Scler. 2016 Nov;22(13):1750-1758. Epub 2016 Feb 11.

PMID:
26869531
17.

Phosphorus recycling potential assessment by a biological test applied to wastewater sludge.

Braak E, Auby S, Piveteau S, Guilayn F, Daumer ML.

Environ Technol. 2016;37(11):1398-407. doi: 10.1080/09593330.2015.1116612. Epub 2016 Jan 19.

PMID:
26786893
18.

A Follow-Up of the Multicenter Collaborative Study on HIV-1 Drug Resistance and Tropism Testing Using 454 Ultra Deep Pyrosequencing.

St John EP, Simen BB, Turenchalk GS, Braverman MS, Abbate I, Aerssens J, Bouchez O, Gabriel C, Izopet J, Meixenberger K, Di Giallonardo F, Schlapbach R, Paredes R, Sakwa J, Schmitz-Agheguian GG, Thielen A, Victor M, Metzner KJ, Däumer MP; 454 HIV-1 Alpha Study Group.

PLoS One. 2016 Jan 12;11(1):e0146687. doi: 10.1371/journal.pone.0146687. eCollection 2016.

19.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

20.

Effects of organic matter on crystallization of struvite in biologically treated swine wastewater.

Capdevielle A, Sýkorová E, Béline F, Daumer ML.

Environ Technol. 2016;37(7):880-92. doi: 10.1080/09593330.2015.1088580. Epub 2015 Oct 23.

PMID:
26495935
21.

Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.

Noguera-Julian M, Cozzi-Lepri A, Di Giallonardo F, Schuurman R, Däumer M, Aitken S, Ceccherini-Silberstein F, D'Arminio Monforte A, Geretti AM, Booth CL, Kaiser R, Michalik C, Jansen K, Masquelier B, Bellecave P, Kouyos RD, Castro E, Furrer H, Schultze A, Günthard HF, Brun-Vezinet F, Metzner KJ, Paredes R; CHAIN Minority HIV-1 Variants Working group.

Clin Microbiol Infect. 2016 Feb;22(2):191-200. doi: 10.1016/j.cmi.2015.10.004. Epub 2015 Oct 23.

22.

Ecological validity of walking capacity tests in multiple sclerosis.

Stellmann JP, Neuhaus A, Götze N, Briken S, Lederer C, Schimpl M, Heesen C, Daumer M.

PLoS One. 2015 Apr 16;10(4):e0123822. doi: 10.1371/journal.pone.0123822. eCollection 2015.

23.

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.

Cozzi-Lepri A, Noguera-Julian M, Di Giallonardo F, Schuurman R, Däumer M, Aitken S, Ceccherini-Silberstein F, D'Arminio Monforte A, Geretti AM, Booth CL, Kaiser R, Michalik C, Jansen K, Masquelier B, Bellecave P, Kouyos RD, Castro E, Furrer H, Schultze A, Günthard HF, Brun-Vezinet F, Paredes R, Metzner KJ; CHAIN Minority HIV-1 Variants Working Group.

J Antimicrob Chemother. 2015 Mar;70(3):930-40. doi: 10.1093/jac/dku426. Epub 2014 Oct 21.

24.

Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations.

Giallonardo FD, Töpfer A, Rey M, Prabhakaran S, Duport Y, Leemann C, Schmutz S, Campbell NK, Joos B, Lecca MR, Patrignani A, Däumer M, Beisel C, Rusert P, Trkola A, Günthard HF, Roth V, Beerenwinkel N, Metzner KJ.

Nucleic Acids Res. 2014 Aug;42(14):e115. doi: 10.1093/nar/gku537. Epub 2014 Jun 27.

25.

An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing.

Simen BB, Braverman MS, Abbate I, Aerssens J, Bidet Y, Bouchez O, Gabriel C, Izopet J, Kessler HH, Stelzl E, Di Giallonardo F, Schlapbach R, Radonic A, Paredes R, Recordon-Pinson P, Sakwa J, St John EP, Schmitz-Agheguian GG, Metzner KJ, Däumer MP; 454 HIV Alphastudy Group.

J Virol Methods. 2014 Aug;204:31-7. doi: 10.1016/j.jviromet.2014.04.007. Epub 2014 Apr 13.

PMID:
24731928
26.

Kinetics of struvite precipitation in synthetic biologically treated swine wastewaters.

Capdevielle A, Sýkorová E, Béline F, Daumer ML.

Environ Technol. 2014 May-Jun;35(9-12):1250-62.

PMID:
24701922
27.

Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.

Stellmann JP, Neuhaus A, Lederer C, Daumer M, Heesen C.

PLoS One. 2014 Mar 20;9(3):e92761. doi: 10.1371/journal.pone.0092761. eCollection 2014. Review.

28.

Imagine a world without cancer.

Brücher BL, Lyman G, van Hillegersberg R, Pollock RE, Lordick F, Yang HK, Ushijima T, Yeoh KG, Skricka T, Polkowski W, Wallner G, Verwaal V, Garofalo A, D'Ugo D, Roviello F, Steinau HU, Wallace TJ, Daumer M, Maihle N, Reid TJ 3rd, Ducreux M, Kitagawa Y, Knuth A, Zilberstein B, Steele SR, Jamall IS.

BMC Cancer. 2014 Mar 14;14:186. doi: 10.1186/1471-2407-14-186.

29.

Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B.

Beggel B, Münk C, Däumer M, Hauck K, Häussinger D, Lengauer T, Erhardt A.

J Viral Hepat. 2013 Dec;20(12):882-9. doi: 10.1111/jvh.12110. Epub 2013 Jun 7.

PMID:
24304458
30.

HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.

Pou C, Codoñer FM, Thielen A, Bellido R, Pérez-Álvarez S, Cabrera C, Dalmau J, Curriu M, Lie Y, Noguera-Julian M, Puig J, Martínez-Picado J, Blanco J, Coakley E, Däumer M, Clotet B, Paredes R.

PLoS One. 2013 Aug 1;8(8):e67085. doi: 10.1371/journal.pone.0067085. Print 2013.

31.

What is the "normal" fetal heart rate?

Pildner von Steinburg S, Boulesteix AL, Lederer C, Grunow S, Schiermeier S, Hatzmann W, Schneider KT, Daumer M.

PeerJ. 2013 Jun 4;1:e82. doi: 10.7717/peerj.82. Print 2013.

32.

Anorectal malignant melanoma: extensive 45-year review and proposal for a novel staging classification.

Falch C, Stojadinovic A, Hann-von-Weyhern C, Protic M, Nissan A, Faries MB, Daumer M, Bilchik AJ, Itzhak A, Brücher BL.

J Am Coll Surg. 2013 Aug;217(2):324-35. doi: 10.1016/j.jamcollsurg.2013.02.031. Epub 2013 May 19. Review. No abstract available.

PMID:
23697834
33.

Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.

Heesen C, Gaissmaier W, Nguyen F, Stellmann JP, Kasper J, Köpke S, Lederer C, Neuhaus A, Daumer M.

PLoS One. 2013 May 17;8(5):e59042. doi: 10.1371/journal.pone.0059042. Print 2013.

34.

Progressive adaptation in physical activity and neuromuscular performance during 520d confinement.

Belavý DL, Gast U, Daumer M, Fomina E, Rawer R, Schießl H, Schneider S, Schubert H, Soaz C, Felsenberg D.

PLoS One. 2013;8(3):e60090. doi: 10.1371/journal.pone.0060090. Epub 2013 Mar 28.

35.

Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients.

Dietz J, Schelhorn SE, Fitting D, Mihm U, Susser S, Welker MW, Füller C, Däumer M, Teuber G, Wedemeyer H, Berg T, Lengauer T, Zeuzem S, Herrmann E, Sarrazin C.

J Virol. 2013 Jun;87(11):6172-81. doi: 10.1128/JVI.02778-12. Epub 2013 Mar 27.

36.

Onset of secondary progressive phase and long-term evolution of multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Muraro PA, Ebers GC.

J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):67-75. doi: 10.1136/jnnp-2012-304333. Epub 2013 Mar 13.

PMID:
23486991
37.

The Diagnostic and Prognostic Role of microRNA in Colorectal Cancer - a Comprehensive review.

Mazeh H, Mizrahi I, Ilyayev N, Halle D, Brücher B, Bilchik A, Protic M, Daumer M, Stojadinovic A, Itzhak A, Nissan A.

J Cancer. 2013;4(3):281-95. doi: 10.7150/jca.5836. Epub 2013 Mar 20.

38.

Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of second look laparotomy.

Brücher B, Stojadinovic A, Bilchik A, Protic M, Daumer M, Nissan A, Itzhak A.

J Cancer. 2013;4(3):262-9. doi: 10.7150/jca.5831. Epub 2013 Mar 15.

39.

Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection.

Summers T, Langan RC, Nissan A, Brücher BL, Bilchik AJ, Protic M, Daumer M, Avital I, Stojadinovic A.

J Cancer. 2013;4(3):210-6. doi: 10.7150/jca.5839. Epub 2013 Mar 1.

40.

Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions.

Avital I, Langan RC, Summers TA, Steele SR, Waldman SA, Backman V, Yee J, Nissan A, Young P, Womeldorph C, Mancusco P, Mueller R, Noto K, Grundfest W, Bilchik AJ, Protic M, Daumer M, Eberhardt J, Man YG, Brücher BL, Stojadinovic A.

J Cancer. 2013;4(3):172-92. doi: 10.7150/jca.5834. Epub 2013 Mar 1.

41.

Early relapses, onset of progression, and late outcome in multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC.

JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599.

PMID:
23407713
42.

A web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.

Galea I, Lederer C, Neuhaus A, Muraro PA, Scalfari A, Koch-Henriksen N, Heesen C, Koepke S, Stellmann P, Albrecht H, Winkelmann A, Weber F, Bahn E, Hauser M, Edan G, Ebers G, Daumer M.

Eur J Neurol. 2013 Jul;20(7):1107-9. doi: 10.1111/ene.12016. Epub 2012 Dec 7.

43.

A new method to estimate the real upper limit of the false alarm rate in a 3 accelerometry-based fall detector for the elderly.

Soaz C, Lederer C, Daumer M.

Conf Proc IEEE Eng Med Biol Soc. 2012;2012:244-7. doi: 10.1109/EMBC.2012.6345915.

PMID:
23365876
44.

Optimization of struvite precipitation in synthetic biologically treated swine wastewater--determination of the optimal process parameters.

Capdevielle A, Sýkorová E, Biscans B, Béline F, Daumer ML.

J Hazard Mater. 2013 Jan 15;244-245:357-69. doi: 10.1016/j.jhazmat.2012.11.054. Epub 2012 Dec 1.

PMID:
23270959
45.

Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data.

Stellmann JP, Neuhaus A, Herich L, Schippling S, Roeckel M, Daumer M, Martin R, Heesen C.

PLoS One. 2012;7(11):e50347. doi: 10.1371/journal.pone.0050347. Epub 2012 Nov 29.

46.

Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.

Portsmouth S, Valluri SR, Däumer M, Thiele B, Valdez H, Lewis M, Craig C, Thielen A, James I, Demarest J, Heera J.

Antiviral Res. 2013 Jan;97(1):60-5. doi: 10.1016/j.antiviral.2012.11.002. Epub 2012 Nov 16.

PMID:
23165088
47.

Read length versus depth of coverage for viral quasispecies reconstruction.

Zagordi O, Däumer M, Beisel C, Beerenwinkel N.

PLoS One. 2012;7(10):e47046. doi: 10.1371/journal.pone.0047046. Epub 2012 Oct 3.

48.

Next-generation sequencing to assess HIV tropism.

Swenson LC, Däumer M, Paredes R.

Curr Opin HIV AIDS. 2012 Sep;7(5):478-85. doi: 10.1097/COH.0b013e328356e9da. Review.

PMID:
22832710
49.

Combined MRI lesions and relapses as a surrogate for disability in MS.

Ebers GC, Scalfari A, Daumer M, Lederer C.

Neurology. 2012 Apr 24;78(17):1367; author reply 1367. doi: 10.1212/WNL.0b013e318255b4fe. No abstract available.

PMID:
22529206
50.

Pregnancy: a "modifiable" risk factor in MS?

Daumer M, Weinshenker BG, Voskuhl R.

Neurology. 2012 Mar 20;78(12):846-8. doi: 10.1212/WNL.0b013e31824d1858. Epub 2012 Mar 7. No abstract available.

PMID:
22402865

Supplemental Content

Loading ...
Support Center